Amerant Bancorp (NASDAQ:AMTB – Free Report) had its price target lowered by Raymond James from $27.00 to $25.00 in a research report report published on Wednesday, Benzinga reports. Raymond James currently has an outperform rating on the stock.
A number of other equities analysts have also commented on AMTB. Piper Sandler upgraded Amerant Bancorp from a neutral rating to an overweight rating and raised their price objective for the stock from $26.00 to $26.50 in a research note on Monday. Keefe, Bruyette & Woods lowered their price objective on Amerant Bancorp from $26.00 to $24.00 and set a market perform rating on the stock in a research note on Monday, July 29th. Stephens upgraded Amerant Bancorp from an equal weight rating to an overweight rating and raised their price objective for the stock from $24.00 to $25.00 in a research note on Monday. Finally, Janney Montgomery Scott lowered Amerant Bancorp from a buy rating to a neutral rating and set a $25.00 price target on the stock. in a research note on Friday, July 26th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and an average price target of $25.10.
View Our Latest Stock Analysis on AMTB
Amerant Bancorp Price Performance
Amerant Bancorp (NASDAQ:AMTB – Get Free Report) last announced its earnings results on Wednesday, July 24th. The company reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.07). The firm had revenue of $98.78 million for the quarter, compared to the consensus estimate of $93.19 million. Amerant Bancorp had a return on equity of 7.78% and a net margin of 3.15%. During the same quarter last year, the business posted $0.24 EPS. Equities research analysts predict that Amerant Bancorp will post 1.33 earnings per share for the current year.
Amerant Bancorp Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Thursday, August 15th were issued a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 1.78%. The ex-dividend date was Thursday, August 15th. Amerant Bancorp’s dividend payout ratio (DPR) is 52.94%.
Institutional Investors Weigh In On Amerant Bancorp
Several hedge funds have recently modified their holdings of AMTB. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Amerant Bancorp by 30.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,172 shares of the company’s stock worth $117,000 after buying an additional 1,197 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in Amerant Bancorp by 23.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,998 shares of the company’s stock worth $272,000 after buying an additional 2,316 shares during the period. Rhumbline Advisers lifted its holdings in Amerant Bancorp by 10.9% during the 2nd quarter. Rhumbline Advisers now owns 46,973 shares of the company’s stock worth $1,066,000 after buying an additional 4,622 shares during the period. BNP Paribas Financial Markets lifted its holdings in Amerant Bancorp by 89.8% during the 1st quarter. BNP Paribas Financial Markets now owns 13,234 shares of the company’s stock worth $308,000 after buying an additional 6,261 shares during the period. Finally, SG Americas Securities LLC acquired a new position in Amerant Bancorp during the 2nd quarter worth about $199,000. Institutional investors and hedge funds own 42.11% of the company’s stock.
Amerant Bancorp Company Profile
Amerant Bancorp Inc operates as the bank holding company for Amerant Bank, N.A. that provides banking products and services to individuals and businesses in the United States and internationally. It offers checking, savings, business, and money market accounts; cash management services; and certificates of deposits.
See Also
- Five stocks we like better than Amerant Bancorp
- Top Biotech Stocks: Exploring Innovation Opportunities
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- 3 Tickers Leading a Meme Stock Revival
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Amerant Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amerant Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.